- Home
- DSS vs EVGN Comparison
DSS vs EVGN Comparison
Compare DSS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- EVGN
- Stock Information
- Founded
- DSS 1984
- EVGN 1999
- Country
- DSS United States
- EVGN Israel
- Employees
- DSS N/A
- EVGN N/A
- Industry
- DSS Containers/Packaging
- EVGN Agricultural Chemicals
- Sector
- DSS Consumer Discretionary
- EVGN Industrials
- Exchange
- DSS Nasdaq
- EVGN Nasdaq
- Market Cap
- DSS 9.1M
- EVGN 9.7M
- IPO Year
- DSS N/A
- EVGN N/A
- Fundamental
- Price
- DSS $1.02
- EVGN $1.60
- Analyst Decision
- DSS
- EVGN Strong Buy
- Analyst Count
- DSS 0
- EVGN 1
- Target Price
- DSS N/A
- EVGN $12.00
- AVG Volume (30 Days)
- DSS 20.9K
- EVGN 805.5K
- Earning Date
- DSS 11-13-2024
- EVGN 11-21-2024
- Dividend Yield
- DSS N/A
- EVGN N/A
- EPS Growth
- DSS N/A
- EVGN N/A
- EPS
- DSS N/A
- EVGN N/A
- Revenue
- DSS $25,019,000.00
- EVGN $7,478,000.00
- Revenue This Year
- DSS N/A
- EVGN $173.12
- Revenue Next Year
- DSS N/A
- EVGN $33.10
- P/E Ratio
- DSS N/A
- EVGN N/A
- Revenue Growth
- DSS N/A
- EVGN 290.29
- 52 Week Low
- DSS $1.00
- EVGN $1.44
- 52 Week High
- DSS $3.46
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- DSS 29.23
- EVGN 29.49
- Support Level
- DSS $1.05
- EVGN $1.66
- Resistance Level
- DSS $1.11
- EVGN $1.78
- Average True Range (ATR)
- DSS 0.07
- EVGN 0.15
- MACD
- DSS -0.02
- EVGN -0.01
- Stochastic Oscillator
- DSS 4.81
- EVGN 20.00
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.